Product Information
TOBRAMYCIN 80 MG/2 ML VIAL is a generic product labeled by Fresenius Kabi USA, LLC, priced at $0.7395 per ML under NDC 63323030602. Its NADAC has been published 309 times since Nov 28, 2013.
FDA first approved this application on Nov 29, 2002. Its Orange Book therapeutic-equivalence code is AP.
Strength
40 mg/mL
Manufacturer
Fresenius Kabi USA, LLCNDC
63323030602
Classification
Generic
Dosage Form
INJECTION, SOLUTION
Route
INTRAMUSCULAR; INTRAVENOUS
Effective Date
8/19/2026
Active Ingredients
TOBRAMYCIN SULFATEApproval Type
Generic (ANDA)
FDA Application
ANDA065122FDA Approved
11/29/2002
TE Code
AP
On Market Since
11/23/2005
Pharmacological Classes
Price Statistics
The NADAC for TOBRAMYCIN 80 MG/2 ML VIAL has been published 309 times since Nov 28, 2013, and over the history we have for it it has declined 42.1%. The table below summarizes its recorded NADAC range and movement.
| Current price | $0.7395 per ML |
|---|---|
| All-time high | $1.4932 (Jan 15, 2014) |
| All-time low | $0.5997 (Mar 18, 2026) |
| 52-week high | $0.8372 |
| 52-week low | $0.5997 |
| Median price | $0.8443 |
| Average price | $0.8464 |
| Largest weekly change | +101.1% (Aug 20, 2014) |
| Weeks tracked | 309 |
| Tracking since | Nov 28, 2013 |
Generic Alternatives
No other NADAC-published product shares this drug's active ingredient and strength in a comparable dosage form. Compare the broader picture on the TOBRAMYCIN SULFATE market page.
Lowest-Cost Alternatives
No alternatives available
Related Drugs
Same classification
Frequently asked questions
What is the NADAC price of TOBRAMYCIN 80 MG/2 ML VIAL?
The current National Average Drug Acquisition Cost (NADAC) for TOBRAMYCIN 80 MG/2 ML VIAL, manufactured by Fresenius Kabi USA, LLC, is $0.7395 per ML (NDC 63323030602), effective Aug 19, 2026.
How has the price of TOBRAMYCIN 80 MG/2 ML VIAL changed over time?
Over the history we have for it, the NADAC for TOBRAMYCIN 80 MG/2 ML VIAL has declined 42.1%. It has been tracked across 309 weekly CMS publications since Nov 28, 2013.
What are the highest and lowest recorded NADAC prices for TOBRAMYCIN 80 MG/2 ML VIAL?
Since Nov 28, 2013, the NADAC for TOBRAMYCIN 80 MG/2 ML VIAL has ranged from a low of $0.5997 (Mar 18, 2026) to a high of $1.4932 (Jan 15, 2014), with a median of $0.8443 per ML.
Are there cheaper alternatives to TOBRAMYCIN 80 MG/2 ML VIAL?
No other NADAC-published product currently shares the active ingredient and strength of TOBRAMYCIN 80 MG/2 ML VIAL in a comparable dosage form, so no direct lower-cost alternative is listed.
Who manufactures TOBRAMYCIN 80 MG/2 ML VIAL?
TOBRAMYCIN 80 MG/2 ML VIAL (NDC 63323030602) is labeled by Fresenius Kabi USA, LLC, and CMS classifies it as a generic product.